NCT04485468

Brief Summary

According to the latest public health report in France, Parkinson's disease (PD) affects around 160,000 patients. It is therefore essential to estimate the overall consumption of medical and non-medical resources by patients with PD in order to characterize the share of medical and non-medical care reimbursed by health insurance, the share of medical and non-medical care not reimbursed. by health insurance, as well as the share of formal and informal care in order to identify potential economic barriers to an optimal care path for patients with PD. It is also necessary to have information on the socio-economic characteristics and the place of residence of the resident in order to estimate the impact of these determinants on an optimal course of care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 21, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 24, 2020

Completed
7 months until next milestone

Study Start

First participant enrolled

February 12, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 2, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 2, 2021

Completed
Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

5 months

First QC Date

July 21, 2020

Last Update Submit

June 19, 2023

Conditions

Keywords

Parkinson Disease,Socio-economic

Outcome Measures

Primary Outcomes (1)

  • Identify the economic barriers to an optimal care path

    It is the collection of the number of resources consumed and the remainder to be borne by the patient as well as the number of hours of informal help that will be valued using the replacement cost approach.

    Day 0

Secondary Outcomes (2)

  • Identify and quantify the cost of the care pathway for patients with Parkinson's disease

    Day 0

  • identify socio-economic determinants

    Day 0

Study Arms (1)

Parkinson's disease patients

Parkinson's disease patients and over 18 years old

Other: Questionnaire

Interventions

The patient answers the questionnaire directly following his consultation or teleconsultation or may arrange a telephone appointment with the clinical research associate a little later.

Parkinson's disease patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Parkinson's disease patients and over 18 years old

You may qualify if:

  • Patients with Parkinson's disease of any stage of severity
  • Patients over 18 years of age
  • Patients living at home
  • Patient consultant at the expert center Parkinson's at Toulouse University Hospital

You may not qualify if:

  • Pregnant and lactating woman
  • Patient under guardianship, curatorship or safeguard of justice
  • Person who does not understand French to be able to answer the questionnaire
  • Patient who participated or participated in the iCare PD project

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Toulouse

Toulouse, 31059, France

Location

MeSH Terms

Conditions

Parkinson Disease

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Olivier Rascol

    University Hospital, Toulouse

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 21, 2020

First Posted

July 24, 2020

Study Start

February 12, 2021

Primary Completion

July 2, 2021

Study Completion

July 2, 2021

Last Updated

June 22, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Locations